These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

681 related articles for article (PubMed ID: 33236439)

  • 1. Cutaneous manifestation during COVID-19 pandemic.
    Galli E; Cipriani F; Ricci G; Maiello N
    Pediatr Allergy Immunol; 2020 Nov; 31 Suppl 26(Suppl 26):89-91. PubMed ID: 33236439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cutaneous manifestations of COVID-19.
    Wang CJ; Worswick S
    Dermatol Online J; 2021 Jan; 27(1):. PubMed ID: 33560783
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous signs in COVID-19 patients: A review.
    Wollina U; Karadağ AS; Rowland-Payne C; Chiriac A; Lotti T
    Dermatol Ther; 2020 Sep; 33(5):e13549. PubMed ID: 32390279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations in an Italian military COVID hub.
    Di Nunno D; Laghi A; Troiani G; Marseglia B; Anelli L; Farina E; Tarricone F; Mammana G; Catalano C; Bonito A; De Capua A; Caramanico G; Blasioli S; Astorino S
    G Ital Dermatol Venereol; 2020 Oct; 155(5):632-635. PubMed ID: 33295741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kawasaki or Kawasaki-like disease? A debate on COVID-19 infection in children.
    Hosseini MS
    Clin Immunol; 2021 Jan; 222():108646. PubMed ID: 33301883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. COVID-19 pandemic and the skin: what should dermatologists know?
    Darlenski R; Tsankov N
    Clin Dermatol; 2020; 38(6):785-787. PubMed ID: 33341217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localized Scarlatiniform Rash of the Ears and Antecubital Fossa in COVID-19.
    Phamduy TT; Young DM; Ramolia PB
    J Am Board Fam Med; 2021 Feb; 34(Suppl):S183-S185. PubMed ID: 33622835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cutaneous Manifestations of COVID-19: Characteristics, Pathogenesis, and the Role of Dermatology in the Pandemic.
    Alam M; Lewis W; Harp J; Steele K; Rosenbach M; Micheletti RG
    Cutis; 2021 Apr; 107(4):209-215. PubMed ID: 34096848
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Skin manifestations of COVID-19 in children: Part 2.
    Andina D; Belloni-Fortina A; Bodemer C; Bonifazi E; Chiriac A; Colmenero I; Diociaiuti A; El-Hachem M; Fertitta L; van Gysel D; Hernández-Martín A; Hubiche T; Luca C; Martos-Cabrera L; Maruani A; Mazzotta F; Akkaya AD; Casals M; Ferrando J; Grimalt R; Grozdev I; Kinsler V; Morren MA; Munisami M; Nanda A; Novoa MP; Ott H; Pasmans S; Salavastru C; Zawar V; Torrelo A;
    Clin Exp Dermatol; 2021 Apr; 46(3):451-461. PubMed ID: 33166429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Children with Kawasaki disease or Kawasaki-like syndrome (MIS-C/PIMS) at the time of COVID-19: are they all the same? Case series and literature review.
    Marino A; Varisco T; Quattrocchi G; Amoroso A; Beltrami D; Venturiello S; Ripamonti A; Villa A; Andreotti M; Ciuffreda M; Cimaz R
    Reumatismo; 2021 Apr; 73(1):48-53. PubMed ID: 33874647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous Manifestations of COVID-19: A Systematic Review.
    Singh H; Kaur H; Singh K; Sen CK
    Adv Wound Care (New Rochelle); 2021 Feb; 10(2):51-80. PubMed ID: 33035150
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin Manifestations Associated with COVID-19: Current Knowledge and Future Perspectives.
    Genovese G; Moltrasio C; Berti E; Marzano AV
    Dermatology; 2021; 237(1):1-12. PubMed ID: 33232965
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The trend of cutaneous lesions during COVID-19 pandemic: lessons from a meta-analysis and systematic review.
    Rajan M B; Kumar-M P; Bhardwaj A
    Int J Dermatol; 2020 Nov; 59(11):1358-1370. PubMed ID: 32936462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kawasaki disease shock syndrome or toxic shock syndrome in children and the relationship with COVID-19.
    Pruc M; Smereka J; Dzieciatkowski T; Jaguszewski M; Filipiak KJ; Szarpak L
    Med Hypotheses; 2020 Nov; 144():109986. PubMed ID: 32562912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous Manifestations Associated with COVID-19: A Narrative Review].
    Relvas M; Calvão J; Oliveira R; Cardoso JC; Gonçalo M
    Acta Med Port; 2021 Feb; 34(2):128-136. PubMed ID: 33315008
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SARS-CoV-2, which induces COVID-19, causes kawasaki-like disease in children: role of pro-inflammatory and anti-inflammatory cytokines.
    Ronconi G; Teté G; Kritas SK; Gallenga CE; Caraffa Al; Ross R; Conti P
    J Biol Regul Homeost Agents; 2020 May-June,; 34(3):767-773. PubMed ID: 32476380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cutaneous lesions in COVID-19 patients].
    Çiftçi Z; Clabbers JMK; Galimont-Collen AFS; Gostyński A
    Ned Tijdschr Geneeskd; 2020 Dec; 164():. PubMed ID: 33332042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lessons From the First Wave of the Pandemic: Skin Features of COVID-19 Can Be Divided Into Inflammatory and Vascular Patterns [Formula: see text].
    Naderi-Azad S; Vender R
    J Cutan Med Surg; 2021; 25(2):169-176. PubMed ID: 33179534
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kawasaki like illness due to COVID-19: a review of the literature.
    Fang Y; Aravamudan VM; Sridharan GK; Mehta KK; Sekhar R; Senguttuvan NB; Venkatachalam I; Abid MB
    J Infect Dev Ctries; 2021 May; 15(5):630-638. PubMed ID: 34106885
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [COVID-19 and skin manifestations: overview of current literature].
    Lange K; Matthies M; Firouzi-Memarpuri P; Homey B
    Hautarzt; 2022 Apr; 73(4):291-297. PubMed ID: 35254461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.